A new mechanism for crossing the blood–brain barrier

The blood–brain barrier (BBB) is a stringent, nearly impenetrable layer of cells that guards the brain, protecting the vital organ from hazards in the bloodstream such as toxins or bacteria and allowing only a very limited set of small molecules, such as nutrients, to pass through. This layer of protection, however, makes it difficult for researchers to study the brain and to design drugs that can treat brain disorders.

Study finds equitable heart failure care, but challenges remain

Black adults with heart failure (HF) are more likely to die than white adults with the same condition. A new study published today in JAMA Cardiology that used the American Heart Association’s Get With The Guidelines—Heart Failure registry data to examine quality and outcomes at hospitals treating high proportions of Black patients with HF found that care is equitable, although areas for improvement remain to examine quality and outcomes at hospitals treating high proportions of Black patients.

Study finds drug may delay earliest symptoms of multiple sclerosis

A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease. The preliminary study, released April 19, 2023, will be presented at the American Academy of Neurology’s 75th Annual Meeting, being held in person in Boston and live online from April 22-27, 2023.